View of SMOKING AS A PREDICTOR OF IMMUNE CHECKPOINT INHIBITOR EFFICACY IN METASTATIC NON-SMALL CELL LUNG CANCER PATIENTS

Return to Article Details SMOKING AS A PREDICTOR OF IMMUNE CHECKPOINT INHIBITOR EFFICACY IN METASTATIC NON-SMALL CELL LUNG CANCER PATIENTS Download Download PDF